We next investigated whether inhibition of hERG/Eag1 channels with the well-established and highly potent inhibitors astemizole and terfenadine (Toplak et al. 2022) induces cytotoxicity in selected glioblastoma cells in MTT experiments. The gene discussed is KCNH2; the disease is glioblastoma.